{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:50:37Z","timestamp":1766267437577,"version":"3.41.2"},"reference-count":24,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2019,4,3]]},"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Liver cirrhosis is the fifth largest cause of adult deaths, and a major complication, variceal bleeding is associated with a 1-year mortality of 40%. There is uncertainty on the first-line therapy for prevention of variceal bleeding owing to a lack of adequately powered trials comparing non-selective beta blockers, in particular carvedilol, with variceal band ligation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>CALIBRE is a multicentre, pragmatic, randomised controlled, open-label trial with an internal pilot. The two interventions are carvedilol 12.5\u2009mg od or variceal band ligation (VBL). Patients with liver cirrhosis and medium to large oesophageal varices that have never bled are eligible for inclusion. The primary outcome is any variceal bleeding within 1\u2009year of randomisation. Secondary endpoints include time to variceal bleed, mortality, transplant-free survival, adverse events, complications of cirrhosis, health-related quality of life, use of healthcare resources, patient preference and use of alternative or crossover therapies. The sample size is 2630 patients over a 4-year recruitment period, across 66 hospitals in the UK.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The study has been approved by a National Health Service (NHS) Research Ethics Committee (REC) (reference number 18\/NE\/0296). The results of this trial will be submitted for publication in a peer reviewed journal. Participants will be informed via a link to a preview of the publication. A lay summary will also be provided via email or posted to participants prior to publication (ISRCTN reference number: 73887615).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgast-2019-000290","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T05:35:11Z","timestamp":1556256911000},"page":"e000290","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9043-6382","authenticated-orcid":false,"given":"Dhiraj","family":"Tripathi","sequence":"first","affiliation":[{"name":"Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Clive","family":"Hayes","sequence":"additional","affiliation":[{"name":"Division of Health Sciences, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Richardson","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Royal Liverpool University Hospital, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Rowe","sequence":"additional","affiliation":[{"name":"Hepatology and Liver Transplantation, University of Leeds, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ferguson","sequence":"additional","affiliation":[{"name":"Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"},{"name":"NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Devine","sequence":"additional","affiliation":[{"name":"Birmingham Liver Public and Patient Involvement Group, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Mathers","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Poyner","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Jowett","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Handley","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Grant","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Slinn","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Brocklehurst","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"2025073013014679000_6.1.e000290.1","unstructured":"Public Health England . The 2nd atlas of variation in risk factors and healthcare for liver disease in England, 2017. Available: https:\/\/fingertips.phe.org.uk\/documents\/FINAL_LiverAtlas.pdf"},{"key":"2025073013014679000_6.1.e000290.2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000208"},{"key":"2025073013014679000_6.1.e000290.3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309262"},{"key":"2025073013014679000_6.1.e000290.4","doi-asserted-by":"crossref","unstructured":"Gluud LL , Krag A , Cochrane Hepato-Biliary Group . Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database Syst Rev 2012;44.doi:10.1002\/14651858.CD004544.pub2","DOI":"10.1002\/14651858.CD004544.pub2"},{"key":"2025073013014679000_6.1.e000290.5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1665-2681(19)30934-2","article-title":"Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding","volume":"11","author":"Funakoshi","year":"2012","journal-title":"Ann Hepatol"},{"key":"2025073013014679000_6.1.e000290.6","unstructured":"NICE . Cirrhosis in over 16S: assessment and management. London: NICE, 2016."},{"key":"2025073013014679000_6.1.e000290.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.05.022"},{"key":"2025073013014679000_6.1.e000290.8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28906"},{"key":"2025073013014679000_6.1.e000290.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.034"},{"key":"2025073013014679000_6.1.e000290.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23775"},{"key":"2025073013014679000_6.1.e000290.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306502"},{"key":"2025073013014679000_6.1.e000290.12","doi-asserted-by":"crossref","unstructured":"Sinha R , Lockman KA , Mallawaarachchi N , et al . Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. J Hepatol 2017.","DOI":"10.1016\/j.jhep.2017.02.005"},{"key":"2025073013014679000_6.1.e000290.13","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21083"},{"key":"2025073013014679000_6.1.e000290.14","doi-asserted-by":"crossref","unstructured":"Reiberger T , Ulbrich G , Ferlitsch A , et al . Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 2012.","DOI":"10.1136\/gutjnl-2012-304038"},{"key":"2025073013014679000_6.1.e000290.15","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283367a99"},{"key":"2025073013014679000_6.1.e000290.16","doi-asserted-by":"crossref","unstructured":"Shah HA , Azam Z , Rauf J , et al . Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial. J.Hepatol 2013.","DOI":"10.14309\/00000434-201210001-00347"},{"key":"2025073013014679000_6.1.e000290.17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23045"},{"key":"2025073013014679000_6.1.e000290.18","doi-asserted-by":"crossref","unstructured":"Bhardwaj A , Kedarisetty CK , Vashishtha C , et al . Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial. Gut 2016.","DOI":"10.1136\/gutjnl-2016-311735"},{"key":"2025073013014679000_6.1.e000290.19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/hep.30220","article-title":"Comparison of therapies for primary prevention of esophageal variceal bleeding: a systematic review and network meta-analysis","volume":"69","author":"Sharma","year":"2019","journal-title":"Hepatology"},{"key":"2025073013014679000_6.1.e000290.20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22358"},{"key":"2025073013014679000_6.1.e000290.21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus Conference of the International ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"2025073013014679000_6.1.e000290.22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"2025073013014679000_6.1.e000290.23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308874"},{"key":"2025073013014679000_6.1.e000290.24","unstructured":"Ritchie J , Lewis J , Nicholls CM , et al . Qualitative research practice: a guide for social science students and researchers. sage, 2013."}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2019-000290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:01:52Z","timestamp":1753905712000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2019-000290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,4,25]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1136\/bmjgast-2019-000290"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2019-000290","relation":{},"ISSN":["2054-4774"],"issn-type":[{"type":"electronic","value":"2054-4774"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}